Click here to download

Perioperative medicine in oncological surgery and PNEI: anaesthesiological strategies about recovery and prognosis
Journal Title: PNEI REVIEW 
Author/s: Davide Gottardello 
Year:  2018 Issue: Language: Italian 
Pages:  13 Pg. 104-116 FullText PDF:  1145 KB
DOI:  10.3280/PNEI2018-002008
(DOI is like a bar code for intellectual property: to have more infomation:  clicca qui   and here 


The oncological disease engages the person in the complexity of her body, mind and relationship. From the diagnosis throughout the perioperative time, the surgical trauma and the psychological dynamics activate a neuroendocrinal response, with metabolic and immunological alterations that can affect the recovery of mental and somatic functions and, perhaps, the prognosis itself. The recent scientific literature is now presenting new knowledge and suggestions about the effects of the interaction between surgery and anaesthetic drugs on immunological functions and intracellular molecular pathways. From a PNEI point of view, it will be possible to design a perioperative program that includes the possibility of a preoperative prehabilitation, a more mindful choice of surgical and anaesthesiological techniques, a control of postoperative catabolism and a management of psychological stress by bodymind techniques. The international protocol ERAS (enhanced recovery after surgery) is presented as an example of how a PNEI view of perioperative medicine can be translated into clinical practice.
Keywords: Perioperative medicine, Anaesthesia, Prehabilitation, Immunonutrition, Meditation, ERAS.

  1. Bower J.E., Crosswell A.D., Stanton A.L., Crespi C.M., Winston D., Arevalo J., Ma J., Cole S.W. and Ganz P.A. (2014). Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial. Cancer, 121(8): 1231-1240.
  2. Braga M., Gianotti L., Vignali A. and Carlo V.D. (2002). Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery, 132: 805-814.
  3. Bragg D., El-Sharkawy A.M., Psaltis E., Maxwell-Armstrong C.A. and Lobo D.N. (2015). Postoperative ileus: recent developments in pathophysiology and management. Clin. Nutr., 34:,367-376.
  4. Cakmakkaya O.S., Kolodzie K., Apfel C.C. and Pace N.L. (2014). Anaesthetic techniques for risk of malignant tumour recurrence. Cochrane Database Syst. Rev., 11: CD008877.
  5. Cho J.S., Lee M.H., Kim S.I., Park S., Park H.S., Oh E., Lee J.H. and Koo B.N. (2017). The Effects of Perioperative Anesthesia and Analgesia on Immune Function in Patients Undergoing Breast Cancer Resection: A Prospective Randomized Study. Int. J. Med. Sci., 14(10): 970-976
  6. Degos V., Vacas S., Han Z., van Rooijen N., Gressens P., Su H., Young W.L. and Maze M. (2013). Depletion of bone marrow-derived macrophages perturbs the innate immune response to surgery and reduces postoperative memory dysfunction. Anesthesiology, 118(3): 527-536.
  7. Feldheiser A., Aziz O., Baldini G., Cox B.P., Fearon K.C., Feldman L.S., Gan T.J., Kennedy R.H., Ljungqvist O., Lobo D.N., Miller T., Radtke F.F., Ruiz Garces T., Schricker T., Scott M.J., Thacker J.K., Ytrebø L.M. and Carli F. (2016). Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, Part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol. Scand., 60(3): 289-334.
  8. Fujitani K., Tsujinaka T., Fujita J., Miyashiro I., Imamura H., Kimura Y., Kobayashi K., Kurokawa Y., Shimokawa T., Furukawa H. and Osaka Gastrointestinal Cancer Chemotherapy Study Group. (2012). Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer. Br. J. Surg., 99(5): 621-629.
  9. Giger-Pabst U., Lange J., Maurer C., Bucher C., Schreiber V., Schlumpf R., Kocher T., Schweizer W., Krähenbühl S. and Krähenbühl L. (2013). Short-term preoperative supplementation of an immunoenriched diet does not improve clinical outcome in well-nourished patients undergoing abdominal cancer surgery. Nutrition, 29: 724-729.
  10. Hulett J.M. and Armer J.M. (2016). A Systematic Review of Spiritually Based Interventions and Psychoneuroimmunological Outcomes in Breast Cancer Survivorship. Integr. Cancer Ther., 15(4): 405-423., 10.1177/153473541663622DOI: 10.1177/153473541663622
  11. Johannsen M., O’Connor M., O’Toole M.S., Jensen A.B., Højris I. and Zachariae R. (2016). Efficacy of mindfulness-based cognitive therapy on late post-treatment pain in women treated for primary breast cancer: a randomized controlled trial. J. Clin. Oncol., 34(28): 3390-3399., 10.1200/JCO.2015.65.077DOI: 10.1200/JCO.2015.65.077
  12. Kern M.A., Haugg A.M., Koch A.F., Schilling T., Breuhahn K., Walczak H., Fleischer B., Trautwein C., Michalski C., Schulze- Bergkamen H., Friess H., Stremmel W., Krammer P.H., Schirmacher P. and Müller M. (2006). Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res., 66: 7059-7066, 10.1158/0008-5472.CAN-06-032DOI: 10.1158/0008-5472.CAN-06-032
  13. Kumar A. and Balkrishna A. (2009). To study the effect of the sequence of seven pranayama by Swami Ramdev on gene expression in leukaemia patients and rapid interpretation of gene expression. J. Clin. Pathol., 62(11): 1052-1053.
  14. Lee E.K., Ahn H.J., Zo J.I., Kim K., Jung D.M. and Park J.H. (2017). Paravertebral Block Does Not Reduce Cancer Recurrence, but Is Related to Higher Overall Survival in Lung Cancer Surgery: A Retrospective Cohort Study. Anesth. Analg., 125(4): 1322-1328., 10.1213/ANE.000000000000234DOI: 10.1213/ANE.000000000000234
  15. Ljungqvist O. (2009). Modulating postoperative insulin resistance by preoperative carbohydrate loading. Best. Pract. Res. Clin. Anaesthesiol., 23: 401-409.
  16. Maltby J.R. (2006). Fasting from midnight--the history behind the dogma. Best. Pract. Res. Clin. Anaesthesiol., 20(3): 363-378.
  17. Miao Y., Zhang Y., Wan H., Chen L. and Wang F. (2010). GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. Biomed. Pharmacother., 64: 583-588.
  18. Mittal D., Gubin M.M., Schreiber R.D. and Smyth M. (2014). New insights into cancer immunoediting and its three component phases – elimination, equilibrium and escape Curr. Opin. Immunol., 27: 16-25.
  19. Müller L., Briere M., Bastide S., Roger C., Zoric L., Seni G., de La Coussaye J.E., Ripart J. and Lefrant J.Y. (2014). Preoperative fasting does not affect haemodynamic status: a prospective, non-inferiority, echocardiography study. Br. J. Anaesth. 112: 835-841.
  20. Pérez-González O., Cuéllar-Guzmán L.F., Soliz J. and Cata J.P. (2017). Impact of regional Anesthesia on Recurrence, Metastasis, and Immune Response in Breast Cancer Surgery: A Systematic Review of the Literature. Reg. Anesth. Pain Med. 42(6): 751-756., 10.1097/AAP.000000000000066DOI: 10.1097/AAP.000000000000066
  21. Piet J., Würtzen H. and Zachariae R. (2012). The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J. Consult. Clin. Psychol., 80: 1007-1020.
  22. 10.1037/a0028329 Retsky M., Rogers R., Demicheli R., Hrushesky W.J., Gukas I., Vaidya J.S., Baum M., Forget P., Dekock M. and Pachmann K. (2012). NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup. Breast Cancer Res. Treat., 134: 881-888.
  23. Sarin A., Chen L.L. and Wick E.C. (2017). Enhanced recovery after surgery-Preoperative fasting and glucose loading-A review. J. Surg. Oncol., 116(5): 578-582.
  24. Sato H., Carvalho G., Sato T., Lattermann R., Matsukawa T. and Schricker T. (2010). The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery. J. Clin. Endocrinol. Metab., 95: 4338-4344.
  25. Schricker T., Gougeon R., Eberhart L., Wykes L., Mazza L., Carvalho G. and Carli F. (2005). Type 2 diabetes mellitus and the catabolic response to surgery. Anesthesiology, 102: 320-326., 10.1097/00000542-200502000-0001DOI: 10.1097/00000542-200502000-0001
  26. Sekandarzad M.W., van Zundert A.A.J., Doornebal C.W. and Hollmann M.W. (2017). Regional anesthesia and analgesia in cancer care: is it time to break the bad news?. Curr. Opin. Anaesthesiol., 30(5): 606-612., 10.1097/ACO.000000000000049DOI: 10.1097/ACO.000000000000049
  27. Shaashua L., Shabat-Simon M., Haldar R., Matzner P., Zmora O., Shabtai M., Sharon E., Allweis T., Barshack I., Hayman L., Arevalo J., Ma J., Horowitz M., Cole S. and Ben-Eliyahu S. (2017). Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial. Clin. Cancer Res., 23(16): 4651-4661., 10.1158/1078-043DOI: 10.1158/1078-043
  28. Thorell A., Nygren J. and Ljungqvist O. (1999). Insulin resistance: a marker of surgical stress. Curr. Opin. Clin. Nutr. Metab. Care, 2: 69-78., 10.1097/00075197-199901000-0001DOI: 10.1097/00075197-199901000-0001
  29. Xu Y.J., Chen W.K., Zhu Y., Wang S.L. and Miao C.H. (2014). Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer. Br. J. Anaesth., 113(Suppl 1): 149-155.
  30. Wong C.S. and Aly E.H. (2016). The effects of enteral immunonutrition in upper gastrointestinal surgery: A systematic review and meta-analysis. Int. J. Surg., 29: 137-150.

Davide Gottardello, Perioperative medicine in oncological surgery and PNEI: anaesthesiological strategies about recovery and prognosis in "PNEI REVIEW" 2/2018, pp. 104-116, DOI:10.3280/PNEI2018-002008

   

FrancoAngeli is a member of Publishers International Linking Association a not for profit orgasnization wich runs the CrossRef service, enabing links to and from online scholarly content